FERMT1 contributes to the epithelial-mesenchymal transition of chronic rhinosinusitis with nasal polyps via PI3K/Akt signaling
- 2 November 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 3) , 113545
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770978)
- Shandong Province Natural Science Foundation (ZR2023MH027)
This publication has 32 references indexed in Scilit:
- Hypoxia disrupts the nasal epithelial barrier by inhibiting PTPN2 in chronic rhinosinusitis with nasal polypsInternational Immunopharmacology, 2023
- Pathogenesis of Nasal Polyposis: Current TrendsIndian Journal of Otolaryngology and Head & Neck Surgery, 2022
- Mechanisms and pathogenesis of chronic rhinosinusitisJournal of Allergy and Clinical Immunology, 2022
- Preoperative Lund‐Mackay computed tomography score is associated with preoperative symptom severity and predicts quality‐of‐life outcome trajectories after sinus surgeryInternational Forum of Allergy & Rhinology, 2018
- Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbuminEuropean Archives of Oto-Rhino-Laryngology, 2017
- Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseasesJournal of Allergy and Clinical Immunology, 2017
- Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transitionJournal of Allergy and Clinical Immunology, 2016
- Immunopathology of chronic rhinosinusitisAllergology International, 2015
- Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2013
- The Lund‐Mackay staging system for chronic rhinosinusitis: How is it used and what does it predict?Otolaryngology–Head and Neck Surgery, 2007